Gå til innholdet


Continuous update on fish health issues though market presence and customer dialogue makes it possible to initiate early phase research and development for new and innovative products.

Our innovative drive is based on the aquaculture industry’s needs to produce safe and healthy seafood.

By combining our broad competencies, experiences and the commitment of our people with dynamic decision processes and ability to adapt to changes, we will remain in the forefront of new technologies and product launches.

In exploring the possibilities within fish health, it is of vital importance to have a clear understanding of the global trends and the specific nature and dynamics behind the prevalent diseases. Further, it is important to identify the financial impact of diseases to the local farms and the industry as a whole.

All our research and development is conducted in accordance with all relevant local, national and international legislation, regulations and guidelines.

> Learn more about our value chain


Samples from diseased fish of a variety of species of different geographical origin are sent directly to our dedicated team of bacteriologists and virologists in R&D for cultivation and characterization. At this stage, the key to success is the joint efforts of our PHARMAQ field force in different regions of the world and cooperation with our external partners including various scientific institutes, fish farmers and fish health personnel.

Cultivation and characterization of virus and bacteria challenge our R&D people. In some cases it even results in identification of previous uncharacterized pathogens.

PHARMAQ actively utilizes IPR actively to secure freedom to operate and to create value and competitive advantages. Several patents and patent applications covering future products and technologies are held by the company.

Research & Development

Identifying the best solutions to our customers' needs for new vaccines and fish health products, requires dedicated and targeted R&D efforts. Effective vaccine solutions to different bacterial and viral diseases depend upon extensive research and development and a broad range of competencies and highly equipped technical facilities.

The causative pathogen for a disease is usually already known before we start development of new vaccine component. Challenges lies in the ability to identify and characterize the best protective antigens, how to produce them and to optimize the way in which the antigens are presented to the fish in order to obtain protection against disease.

The rate of success of introducing new products and development of efficient processes is founded on the firm commitment to re-invest in R&D and related competencies in the PHARMAQ value chain.

Documentation and registration

Documentation requirements for new products are strictly regulated. Through all steps of research, development and product testing the interaction with the PHARMAQ regulatory department is essential in establishing high quality product documentation for different regulatory bodies around the world.

Our vaccines and therapeutics hold veterinary medicinal product licenses in each country in which they are sold. These licenses certify to the quality, safety, efficacy and environmental effects of each product in the local environment.


All PHARMAQ's vaccines are manufactured at our well recognized facility at Overhalla in Norway. Specific diseases in different farmed fish species and regions need separate vaccine and therapeutic solutions. Careful production planning and logistics combined with flexibility, new ideas and core competencies in vaccine manufacturing make this possible.

Quality is documented in every step from preparation of seed material to final product and throughout the product life cycle. Our quality system ensures that the defined product is manufactured and tested the same way every time, securing that the final product meets the requirements regarding quality, safety and efficacy. The final products are released by a Qualified Person (QP), approved by the authorities. As a pharmaceutical company we are frequently inspected by different national regulatory authorities in order to prove our standards.

Customer Service

By providing environmentally sound, safe and efficacious health products and services to our global aquaculture customers, we will continue to meet our main objective namely to be selected by our customers as their preferred supplier and partner. We put pride in being flexible and create customer satisfaction through high quality service and products.

We can only be successful in this effort if our customers produce predictable yields and healthy profits.

PHARMAQs Pharmacovigilance system is an integral part of post marketing activities in the field of veterinary medicinal products.

Did you know...

We allocate around 18% of our revenue to research and development to provide environmentally sound, safe and efficacious products for the aquaculture industry.


Head office
Production facility
Skogmo Industriområde
Industrivegen 50
7863 Overhalla, Norway
Tel:+47 74 28 08 00
Fax:+47 74 28 08 01

Oslo office
Harbitzalléen 2A, 0275 Oslo,
P.O.Box 267 Skøyen, N-0213 Oslo, Norway
Tel: +47 23 29 85 00
Fax: :+47 23 29 85 01


PHARMAQ AS Chile Ltda.
Bernardino # 1981, Piso 2, Oficina 202,
Parque Empresarial San Andrés,
Puerto Montt, Chile
Tel: +56 65 248 3091


United Kingdom

Unit 15 Sandleheath Industrial Estate,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
Fax: +44-1425 657992

Terms & Conditions of Purchase
Terms & Conditions of Sale
Tax strategy and Disclosure: Financial year ending 30 November 2017


PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
Tel: +90 232 422 23 10
Fax:+90 232 422 32 27


8th Fl. , R. 8.5A, E Town Tower
364 Cong Hoa, W.13, D.Tan Binh
Ho Chi Minh City
Tel : +84 08 3812 2461
Fax : +84 08 3812 2712


PHARMAQ CA Panama Inc.
P.H. Albrook Commercial Park, piso 2,
Oficina 108 Ave. Bella Vista, Ancón
Panamá – Panamá
Phone: +507 3215363
Mob.: +507 6675 1109


PHARMAQ Spain Aqua
Avda de Europa 20B
Parque Empresarial La Moraleja
28108 Alcobendas, Spain
Tel: +34 91 419 19 35


PHARMAQ part of Zoetis
108 Pasir Panjang Road
Singapore 118535, Singapore
Tel.: +65 6933 5800

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.comPrivacy Policy. Cookie Policy. Terms of Use.

Copyright © 2016 Zoetis LLC. All rights reserved.

Utviklet av Imaker as